CTCs can serve as a biomarker for monitoring CRC therapeutic efficacy, predicting prognosis, and guiding subsequent treatment, and can serve as a biomarker for monitoring treatment response and predicting survival.
Yu-Hao Wang, Shan Wang, Lin Yao et al.· Critical reviews in oncology...· 0 citations
This review looks at ADC-based combination strategies in NSCLC, grouped by key molecular targets such as Trop-2, HER2, HER3, c-Met, B7-H3, CEACAM5, and ITGβ6, along with bispecific ADCs.
Yunqi Mi, Shan Wang, Yuhao Wang et al.· Expert Opinion on Biological...· 0 citations
A lightweight training framework that learns a single Behavior-Equivalent Token that substantially reduces inference cost and frees nearly the entire context window for user inputs and model outputs.
Jiancheng Dong, Pengyue Jia, Jingyu Peng et al.· 2 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.